1. ScholarBank@NUS

Si-Shen Feng

rp04215

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Si-Shen Feng
Variants
Feng S.-S.
Feng, S.S.
Feng, S.S
Feng, S.
Si-Shen, F.
Feng, S.-s.
Feng, S.-S.
Shen, F.S.
 
Main Affiliation
 
Faculty
 
Email
chefss@nus.edu.sg
 

Publications

Results 61-80 of 166 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
6114-May-2002Molecular interactions between a lipid and an antineoplastic drug paclitaxel (taxol) within the lipid monolayer at the air/water interfaceFeng, S.-S. ; Gong, K.; Chew, J.
6214-May-2002Molecular interactions between a lipid and an antineoplastic drug paclitaxel (taxol) within the lipid monolayer at the air/water interfaceFeng, S.-S. ; Gong, K.; Chew, J.
632000Molecular interactions between lipid and paclitaxel (Taxol®) within cell membrane simulated by the lipid monolayer at the air-water interfaceGong, K.; Feng, S. ; Chew, J.; Zhao, L. 
642000Molecular interactions between lipid and paclitaxel (Taxol®) within cell membrane simulated by the lipid monolayer at the air-water interfaceGong, K.; Feng, S. ; Chew, J.; Zhao, L. 
65Apr-2010Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatmentPan, J.; Liu, Y.; Feng, S.-S. 
66Feb-2008Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancerSun, B.; Ranganathan, B. ; Feng, S.-S. 
6715-Dec-2011Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agentsLiu, Y.; Mi, Y.; Zhao, J.; Feng, S.-S. 
68Apr-2011Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-d-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticlesTan, Y.F.; Chandrasekharan, P.; Maity, D.; Yong, C.X.; Chuang, K.-H.; Zhao, Y.; Wang, S. ; Ding, J. ; Feng, S.-S. 
69Oct-2012Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymersMi, Y.; Liu, X.; Zhao, J.; Ding, J. ; Feng, S.-S. 
70Feb-2013Nanohydrogels as a prospective member of the nanomedicine familyQian, Z.-Y.; Fu, S.-Z.; Feng, S.-S. 
71Jan-2012Nanoimmunotherapy: Application of nanotechnology for sustained and targeted delivery of antigens to dendritic cellsZhang, Z.; Guo, Y.; Feng, S.-S. 
72Apr-2012Nanomedicine against multidrug resistance in cancer treatmentGao, J.; Feng, S.-S. ; Guo, Y.
73Oct-2011Nanomedicine for diabetes treatmentSung, H.-W.; Sonaje, K.; Feng, S.-S. 
74Dec-2012Nanomedicine for multimodality treatment of cancerMi, Y.; Guo, Y.; Feng, S.-S. 
75Apr-2011Nanomedicine for oral chemotherapyFeng, S.-S. ; Zhao, L.; Tang, J.
762010Nanomedicine: Enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulationGan, C.W.; Chien, S.; Feng, S.-S. 
77Feb-2004Nanoparticles of biodegradable polymers for clinical administration of paclitaxelFeng, S.-S. ; Mu, L. ; Win, K.Y. ; Huang, G.
18Sep-2004Nanoparticles of biodegradable polymers for new-concept chemotherapyFeng, S.-S. 
19Aug-2010Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performanceLiu, Y.; Pan, J.; Feng, S.-S. 
20Jul-2006Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxelDong, Y. ; Feng, S.-S.